Synthesis and SAR of 2-Aryloxy-4-alkoxy-pyridines as Potent Orally Active Corticotropin-Releasing Factor 1 Receptor Antagonists

Citations Over TimeTop 20% of 2008 papers

Abstract

A series of 2-aryloxy-4-alkoxy-pyridines ( 1) was identified as novel, selective, and orally active antagonists of the corticotropin-releasing factor 1 (CRF 1) receptor. Among these, compound 2 (CP-316311) is a potent and selective CRF 1 receptor antagonist with an IC 50 value of 6.8 nM in receptor binding and demonstrates oral efficacy in central nervous system (CNS) in vivo models. The regiochemistry of compounds in this series was determined by an X-ray structural analysis. A method to control regioselectivity via pyridine- N-oxides was developed. The synthesis of compounds in series 1 (Figure ) and [ (3)H]- 2 as well as the structure-activity relationship (SAR) are discussed. The in vitro, ex vivo, and in vivo properties of representative compounds are described herein. Compound 2 was advanced to phase II depression trials to test the hypothesis that CRF 1 antagonists could be used clinically as antidepressant drugs.

Related Papers

• → NUCLEOPHILIC SUBSTITUTION IN N-ALKOXY-N-CHLOROCARBAMATES AS A WAY TO N-ALKOXY-N’,N’,N’-TRIMETHYLHYDRAZINIUM CHLORIDES(2020)8 cited
• → In Vivo Pharmacologic Profile of ONO-1078: A Potent, Selective and Orally Active Peptide Leukotriene (LT) Antagonist.(1992)86 cited
• → 4-Alkoxy-4′-(Alkyl or Alkoxy)-2- Hydroxy-α, α'-Dimethylbenzalazines (III); Some Interesting Mesomorphic Compounds(1983)7 cited
• [ -aminoketones from 4-n-alkoxy-n-alkoxy-3-ethylacetophenones with anesthetic effect].(1973)
• → ChemInform Abstract: 2‐ALKOXY‐ AND 2,2‐DIALKOXYNITRILES FROM ACETALS AND ORTHO ESTERS: EXCHANGE OF ALKOXY INTO CYANO GROUP BY MEANS OF CYANOTRIMETHYLSILANE(1982)